Cargando…

Marinobufagenin, Left Ventricular Hypertrophy and Residual Renal Function in Kidney Transplant Recipients

Background: Left ventricular hypertrophy (LVH), which is a pervasive complication of end-stage kidney disease (ESKD), persists in some uremic individuals even after kidney transplantation (Ktx), contributing to worsening CV outcomes. Marinobufagenin (MBG), an endogenous steroid cardiotonic hormone e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bolignano, Davide, Greco, Marta, Presta, Pierangela, Caglioti, Alfredo, Carullo, Nazareno, Zicarelli, Mariateresa, Foti, Daniela Patrizia, Dragone, Francesco, Andreucci, Michele, Coppolino, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179363/ https://www.ncbi.nlm.nih.gov/pubmed/37176512 http://dx.doi.org/10.3390/jcm12093072

Ejemplares similares

New Insights on the Role of Marinobufagenin from Bench to Bedside in Cardiovascular and Kidney Diseases
por: Carullo, Nazareno, et al.
Publicado: (2023)

Circulating Omentin-1, Sustained Inflammation and Hyperphosphatemia at the Interface of Subclinical Atherosclerosis in Chronic Kidney Disease Patients on Chronic Renal Replacement Therapy
por: Bolignano, Davide, et al.
Publicado: (2022)

Urinary Marinobufagenin in Patients with Non-Advanced Chronic Kidney Disease: A Cross-Sectional Study
por: Bolignano, Davide, et al.
Publicado: (2023)

miRNAs in Uremic Cardiomyopathy: A Comprehensive Review
por: D’Agostino, Mario, et al.
Publicado: (2023)

Retarding Progression of Chronic Kidney Disease in Autosomal Dominant Polycystic Kidney Disease with Metformin and Other Therapies: An Update of New Insights
por: Carullo, Nazareno, et al.
Publicado: (2021)

Circulating Omentin-1 levels and altered iron balance in chronic haemodialysis patients
por: Bolignano, Davide, et al.
Publicado: (2021)

Role of Vitamin K in Chronic Kidney Disease: A Focus on Bone and Cardiovascular Health
por: Bellone, Federica, et al.
Publicado: (2022)

Self-Reported Physical Inactivity and Mood Disturbances in End-Stage Kidney Disease (ESKD) Patients on Chronic Dialysis Treatment
por: Musolino, Michela, et al.
Publicado: (2023)

Circulating miRNA 122-5p Expression Predicts Mortality and Cardiovascular Events in Chronic Hemodialysis Patients: A Multicentric, Pilot, Prospective Study
por: Duni, Anila, et al.
Publicado: (2023)

A small circulating miRNAs signature predicts mortality and adverse cardiovascular outcomes in chronic hemodialysis patients
por: Bolignano, Davide, et al.
Publicado: (2023)

A Rare Complication of Ascariasis: A Case of Acute Interstitial Nephritis
por: Carullo, Nazareno, et al.
Publicado: (2023)

Marinobufagenin Inhibits Neutrophil Migration and Proinflammatory Cytokines
por: Carvalho, Deyse C. M., et al.
Publicado: (2019)

Hyperkalemia in CKD: an overview of available therapeutic strategies
por: Costa, Davide, et al.
Publicado: (2023)

Canrenone Restores Vasorelaxation Impaired by Marinobufagenin in Human Preeclampsia
por: Agalakova, Natalia I., et al.
Publicado: (2022)

Tumour Markers and Kidney Function: A Systematic Review
por: Coppolino, Giuseppe, et al.
Publicado: (2014)

The Cardiotonic Steroid Marinobufagenin Is a Predictor of Increased Left Ventricular Mass in Obesity: The African-PREDICT Study
por: Strauss-Kruger, Michél, et al.
Publicado: (2020)

Acquisition of optical coherence tomography angiography metrics during hemodialysis procedures: A pilot study
por: Coppolino, Giuseppe, et al.
Publicado: (2022)

Antibody to Marinobufagenin Reverses Placenta-Induced Fibrosis of Umbilical Arteries in Preeclampsia
por: Fedorova, Olga V., et al.
Publicado: (2018)

Influence of Endogenous Cardiac Glycosides, Digoxin, and Marinobufagenin in the Physiology of Epithelial Cells
por: Ogazon del Toro, Alejandro, et al.
Publicado: (2019)

Unraveling Cardiovascular Risk in Renal Patients: A New Take on Old Tale
por: Provenzano, Michele, et al.
Publicado: (2019)

Genetic Control of Serum Marinobufagenin in the Spontaneously Hypertensive Rat and the Relationship to Blood Pressure
por: Dmitrieva, Renata I., et al.
Publicado: (2017)

Biomarkers of cardio-renal damage in chronic kidney disease: one size cannot fit all
por: Bolignano, Davide, et al.
Publicado: (2014)

Effect of Cardiotonic Steroid Marinobufagenin on Vascular Remodeling and Cognitive Impairment in Young Dahl-S Rats
por: Grigorova, Yulia N., et al.
Publicado: (2022)

Urinary Neutrophil Gelatinase-Associated Lipocalin (NGAL) Predicts Renal Function Decline in Patients With Glomerular Diseases
por: Coppolino, Giuseppe, et al.
Publicado: (2020)

Comparison of Neurocognitive Testing and the Measurement of Marinobufagenin in Mild Traumatic Brain Injury: A Preliminary Report
por: Oliver, Joel, et al.
Publicado: (2015)

Ca(2+)-Driven Selectivity of the Effect of the Cardiotonic Steroid Marinobufagenin on Rabbit Sinoatrial Node Function
por: Segal, Sofia, et al.
Publicado: (2023)

Left Ventricular Hypertrophy and Hypertrophic Cardiomyopathy in Adult Solid Organ Transplant Recipients
por: Reza, Nosheen, et al.
Publicado: (2021)

Utility of Blood Flow/Resistance Index Ratio (Q(x)) as a Marker of Stenosis and Future Thrombotic Events in Native Arteriovenous Fistulas
por: Colombo, Alessandro, et al.
Publicado: (2021)

The endogenous cardiotonic steroid Marinobufagenin and decline in estimated glomerular filtration rate at follow-up in patients with arterial hypertension
por: Keppel, Martin H., et al.
Publicado: (2019)

Pentoxifylline for Anemia in Chronic Kidney Disease: A Systematic Review and Meta-Analysis
por: Bolignano, Davide, et al.
Publicado: (2015)

Biotic Supplements for Renal Patients: A Systematic Review and Meta-Analysis
por: Pisano, Anna, et al.
Publicado: (2018)

Rapamycin Attenuates Cardiac Fibrosis in Experimental Uremic Cardiomyopathy by Reducing Marinobufagenin Levels and Inhibiting Downstream Pro‐Fibrotic Signaling
por: Haller, Steven T., et al.
Publicado: (2016)

Dietary Sodium Restriction Reduces Arterial Stiffness, Vascular TGF-β-Dependent Fibrosis and Marinobufagenin in Young Normotensive Rats
por: Grigorova, Yulia N., et al.
Publicado: (2018)

OCT angiography metrics predict intradialytic hypotension episodes in chronic hemodialysis patients: a pilot, prospective study
por: Coppolino, Giuseppe, et al.
Publicado: (2021)

Smoking habit as a risk amplifier in chronic kidney disease patients
por: Provenzano, Michele, et al.
Publicado: (2021)

The Association of Long-Functioning Hemodialysis Vascular Access with Prevalence of Left Ventricular Hypertrophy in Kidney Transplant Recipients
por: Kolonko, Aureliusz, et al.
Publicado: (2014)

New-Onset Diabetes and Glucose Regulation Are Significant Determinants of Left Ventricular Hypertrophy in Renal Transplant Recipients
por: Sezer, Siren, et al.
Publicado: (2015)

Hypoxia-Inducible Factor Stabilizers in End Stage Kidney Disease: “Can the Promise Be Kept?”
por: Crugliano, Giuseppina, et al.
Publicado: (2021)

Marinobufagenin inhibits glioma growth through sodium pump α1 subunit and ERK signaling‐mediated mitochondrial apoptotic pathway
por: Lan, Yu‐Long, et al.
Publicado: (2018)

The Effects of Short-Term Changes in Sodium Intake on Plasma Marinobufagenin Levels in Patients with Primary Salt-Sensitive and Salt-Insensitive Hypertension
por: Łabno-Kirszniok, Katarzyna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kcu6cgsj73gkvi1jkua769k447